NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/21/2025
Back to search
Official data from USPTO
AOP ORPHAN FOCUS ON RARE DISEASES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079192641Class
5, 35, 39, 42, 44
Filing
79192641
Registration
5225397
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/23/2025
Trademark type
Combined
Nice classes
5, 35, 39, 42, 44
Filing date
06/02/2016
Registration date
06/20/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/05/2024
Last transaction
11/23/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
AT
Examiner
SHANOSKI,JOANNA MARIE
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "AOP ORPHAN FOCUS ON RARE DISEASES" in gray. To the left of the wording appears a design of two ellipses and two circles in red forming an arc and decreasing in size, with the largest ellipse laying flat, the next ellipse partially raised from the flat ellipse, and the two smaller circles appearing to be floating in the air.
Holders and representatives
Holders
AOP Orphan Pharmaceuticals GmbH
AOP Orphan Pharmaceuticals AG
Representatives
Michael Fedrick Loza & Loza, LLP
Technical classification
Nice Classes
Class 5Class 35Class 39Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medical preparations for the treatment of hematologyoncologycardiologyneurologypsychiatrymetabolic diseases and genetic disorders; sanitary preparations for medical purposes
Class 35
Advertisingmarketing and promotional consultancy in the field of medication
Class 39
Distribution servicesnamely delivery of medications
Class 42
Medical and pharmaceutical research and development in the field of hematologyoncologycardiologyneurologypsychiatrymetabolic diseases and genetic disorders; scientific research and development services in the field of hematologyoncologycardiologyneurologypsychiatrymetabolic diseases and genetic disorders; industrial research in the field of hematologyoncologycardiologyneurologypsychiatrymetabolic diseases and genetic disorders; professional consultancy services in the fields of medical and pharmaceutical research and development; contract research services in the field of hematologyoncologycardiologyneurologypsychiatrymetabolic diseases and genetic disorders; computer programming
Class 44
Medical advisory and assistance services in the field of medication
Publications
History of USPTO decisions and trademark events.
33 publications found
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/29/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/11/2024
INPC
INVALIDATION PROCESSED
09/11/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
09/06/2024
C71T
CANCELLED SECTION 71
01/05/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
06/20/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/18/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/26/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/28/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/22/2017
FIMP
FINAL DISPOSITION PROCESSED
09/22/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/20/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2017
PUBO
PUBLISHED FOR OPPOSITION
04/04/2017
GPNX
NOTIFICATION PROCESSED BY IB
04/01/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/15/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/15/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/28/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/27/2017
RFNT
REFUSAL PROCESSED BY IB
11/25/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/04/2016
RFRR
REFUSAL PROCESSED BY MPU
11/04/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/16/2016
CNRT
NON-FINAL ACTION WRITTEN
10/15/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/11/2016
DOCK
ASSIGNED TO EXAMINER
10/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/01/2016
Continuous trademark protection
Get notified about every new filing that threatens AOP ORPHAN FOCUS ON RARE DISEASES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.